Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Submitted by
admin
on August 20, 2010 - 12:45pm
Source:
Forbes
News Tags:
Eli Lilly
Alzheimer's disease
Pfizer
Elan
Bristol-Myers Squibb
Headline:
Eli Lilly Setback Could Pave Way For New Alzheimer’s Approach
Do Not Allow Advertisers to Use My Personal information
